Jump Financial, LLC Celldex Therapeutics, Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$27.78 - $45.38 $590,408 - $964,461	21,253 New	21,253 $947,000
Q3 2021 Nov 12, 2021	SELL	$28.95 - $55.99 $1.49 Million - $2.88 Million	-51,400 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$20.71 - $35.37 $1.06 Million - $1.82 Million	51,400 New	51,400 $1.72 Million
Q1 2021 May 17, 2021	SELL	$16.19 - $29.91 $212,089 - $391,821	-13,100 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$14.99 - $22.75 $196,369 - $298,025	13,100 New	13,100 $229,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.